Newsletter
Newsday – Glen Tullman CEO of Transcarent from HLTH 2021

This Week In Health IT

Newsday – Glen Tullman CEO of Transcarent from HLTH 2021

October 25, 2021

Newsday – Glen Tullman CEO of Transcarent from HLTH 2021

You may also like

Subscribe to Health Podcast Network

Join Our Newsletter

Proudly supported by:

cover
Adopting Clinical Trial Technology: The Key to Success for Patients, Sites, & Researchers Adoption of new clinical trial technologies is critical to success. These innovations can lift patient burden, improve patient engagement, and increase equity and access to clinical trials.